Clinical Trials Insight: 700038511

Trial Profile

Clinical Trials Insight: 700038511

Phase of Trial: Phase I

Latest Information Update: 30 Oct 2009

At a glance

  • Drugs PHX-1766 (Primary)
  • Indications Chronic hepatitis; Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Phenomix Corporation
  • Most Recent Events

    • 30 Oct 2009 Status changed from recruiting to completed, based on results reported at the AASLD meeting.
    • 30 Oct 2009 Results reported at 60th Annual Meeting of the American Association of the Study of Liver Diseases.
    • 07 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top